These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Köker MY, Sanal O, van Leeuwen K, de Boer M, Metin A, Patiroğlu T, Ozgür TT, Tezcan I, Roos D. Eur J Clin Invest; 2009 Oct; 39(10):942-51. PubMed ID: 19624736 [Abstract] [Full Text] [Related]
8. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease. Barese CN, Copelli SB, De Matteo E, Zandomeni R, Salgueiro F, Di Giovanni D, Heyworth P, Rivas EM. Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310 [Abstract] [Full Text] [Related]
14. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB. Stasia MJ, Brion JP, Boutonnat J, Morel F. J Infect Dis; 2003 Nov 15; 188(10):1593-604. PubMed ID: 14624387 [Abstract] [Full Text] [Related]
15. Prenatal diagnosis of X-linked chronic granulomatous disease by percutaneous umbilical blood sampling. Sun J, Wang Y, Liu D, Yu Y, Wang J, Ying W, Wang X. Scand J Immunol; 2012 Nov 15; 76(5):512-8. PubMed ID: 22924737 [Abstract] [Full Text] [Related]
17. Chronic granulomatous disease in Latin American patients: clinical spectrum and molecular genetics. Agudelo-Flórez P, Prando-Andrade CC, López JA, Costa-Carvalho BT, Quezada A, Espinosa FJ, de Souza Paiva MA, Roxo P, Grumach A, Jacob CA, Carneiro-Sampaio MM, Newburger PE, Condino-Neto A. Pediatr Blood Cancer; 2006 Feb 15; 46(2):243-52. PubMed ID: 16123991 [Abstract] [Full Text] [Related]
19. Exon skipping in CYBB mRNA and skewed inactivation of X chromosome cause late-onset chronic granulomatous disease. Eguchi M, Yagi C, Tauchi H, Kobayashi M, Ishii E, Eguchi-Ishimae M. Pediatr Hematol Oncol; 2018 Feb 15; 35(5-6):341-349. PubMed ID: 30633606 [Abstract] [Full Text] [Related]
20. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. Jirapongsananuruk O, Malech HL, Kuhns DB, Niemela JE, Brown MR, Anderson-Cohen M, Fleisher TA. J Allergy Clin Immunol; 2003 Feb 15; 111(2):374-9. PubMed ID: 12589359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]